Elgar Fleisch

Angel investor in Switzerland

Invests in AI

AI is one of the sectors on Elgar Fleisch's investor profile, next to Healthcare & Biotech, Biotech & Pharma and MedTech & Medical Devices, at pre-seed and seed. The record holds 4 deals, including Robert Bosch GmbH, Gebert Rüf Stiftung and Nostos Genomics.

Email Investor

Email Investor

Credits to line up before a pre-seed round

Elgar Fleisch backs companies at pre-seed and seed. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Robert Bosch GmbH
  • Gebert Rüf Stiftung
  • Nostos Genomics
  • UNIQA

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Biotech & Pharma, MedTech & Medical Devices, SaaS & Enterprise, Climate & Energy and 6 more
Rounds
Pre-seed, Seed
Profile
Angel investor
Deals on record
4
Based in
Switzerland

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Elgar Fleisch invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Elgar Fleisch's investor profile, together with Healthcare & Biotech, Biotech & Pharma and MedTech & Medical Devices. The stages on record are pre-seed and seed.
Which companies has Elgar Fleisch backed?
The record lists 4 deals, including Robert Bosch GmbH, Gebert Rüf Stiftung, Nostos Genomics and UNIQA. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Elgar Fleisch?
For a company raising a pre-seed round, AI Perks lists credits such as MongoDB (up to $25,000), Confluent (up to $20,000), Aiven (up to $100,000) and Algolia (up to $10,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor